Barclays upgrades Stryker stock to strong buy
Published on 10/08/2026 at 15:57 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Stryker Corp. (ISIN US8636671013) was trading at EUR 246.45 at Lang & Schwarz on October 8, 2026 at 3:42 p.m. CEST, up 0.18 percent versus the prior close of EUR 246.00. According to MarketBeat, Barclays upgraded Stryker to a strong-buy rating in a report issued on October 7, 2026.
Analyst support meets a lower price
MarketBeat said one analyst rated Stryker Strong Buy, 17 issued Buy ratings and six assigned Hold ratings. The same overview put the average price target at USD 370.68, while the stock's primary-market quote was USD 276.15 on October 8, 2026.
The contrast matters because the Lang & Schwarz euro quote remains close to the lower end of the primary-market range of USD 267.00 to USD 392.55. Stryker's market capitalization stood at USD 105.9 billion on October 8, 2026, giving the analyst upgrade a valuation context rather than making it a standalone signal.
Second-quarter growth still carries weight
Fortune reported that Stryker's second-quarter 2026 revenue reached USD 6.59 billion, up 9.4 percent from the second quarter of 2025. Adjusted earnings per share were USD 3.69, USD 0.20 above consensus, while adjusted earnings per share rose 17.9 percent year over year.
The operating picture was not uniform. Management said second-quarter organic sales growth was 9.00 percent, but Peripheral Vascular sales declined 6.7 percent because of an operational disruption. That counter-factor leaves execution and supply recovery as important tests for the next results report.
What the transition means for growth
FinanzNachrichten reported on October 6, 2026 that Spencer Stiles will become chief executive officer on January 1, 2027, while Kevin Lobo becomes executive chair. The release said Stryker completed more than 60 acquisitions during Lobo's tenure and annual net sales grew from USD 8.7 billion in 2012 to more than USD 26 billion in 2026.
Upcoming dates set the next test
Yahoo Finance reported that Stryker is scheduled to publish third-quarter 2026 results on October 29, 2026, with consensus revenue of USD 6.638 billion and earnings per share of USD 3.57. The leadership transition is scheduled for January 1, 2027, according to the October 6 company announcement carried by FinanzNachrichten.
Stock awaits the next report
Stryker's euro quote was EUR 246.45 at Lang & Schwarz on October 8, 2026 at 3:42 p.m. CEST, plus 0.18 percent versus the EUR 246.00 prior close dated October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Stryker Corp. stock.
Stryker Corp. stock facts
- Company: Stryker Corporation
- ISIN: US8636671013
- Ticker: SYK
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 8, 2026, 3:42 p.m. CEST: EUR 246.45
- Change versus prior close: plus 0.18 percent
- Prior close Lang & Schwarz (October 7, 2026): EUR 246.00
- Market capitalization: USD 105.9 billion (as of October 8, 2026)
- 52-week range: USD 267.00-392.55 (as of October 8, 2026)
- Sector / Industry: Healthcare / Medical Devices
- Next earnings date: October 29, 2026
Market context: Market report S&P 500.
